The European Commission announced on Tuesday 10 January that it is giving the go-ahead to France’s plan to grant state aid to nuclear company Areva in the form of a capital injection of €4.5 billion. The Commission says Areva's restructuring plan will allow the company to become viable without unduly distorting competition in the Single Market.
Payment of the state aid is subject to conditions, in particular a positive conclusion of the ongoing tests by the French Nuclear Safety Agency...